Kidney Carcinoma Molecular Subtypes — Trials

Kidney Carcinoma Molecular Subtypes — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05877820	A Study to Evaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCC	completed	Phase 2	20	RenJi HospitalOTHER	1	Sep 10, 2026	clinicaltrials
NCT00898365	Study of Kidney Tumors in Younger Patients	completed	—	8,000	Children's Oncology GroupNETWORK	7	May 18, 2026	clinicaltrials